Race Oncology Ltd
Company Profile
Business description
Race Oncology Ltd is an clinical stage biopharmaceutical company focusing on cancer treatment. Its asset bisantrene, is a small molecule chemotherapeutic. Bisantrene has a clinical history with demonstrated therapeutic benefits in both adult & paediatric patients, a well characterised safety profile, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. Race's reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations, where it could deliver cardioprotection and enhanced anti-cancer activity in solid tumours. The company is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia.
Contact
1 Macquarie Place
Level 36, Gateway
Sydney NSW 2000
AUST: +61 280513043
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
video
Can Crowdstrike stock recover from IT outage chaos?
stocks
CSL results: ASX 200 giant announces solid earnings but shares fall
stocks
Warren Buffett is selling these 2 stocks. Should you?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,070.20 | 28.00 | 0.35% |
| CAC 40 | 7,310.58 | 34.71 | 0.48% |
| DAX 40 | 17,844.47 | 32.42 | 0.18% |
| Dow JONES (US) | 39,799.64 | 34.00 | 0.09% |
| FTSE 100 | 8,261.60 | 26.37 | 0.32% |
| HKSE | 17,113.36 | 60.70 | -0.35% |
| NASDAQ | 17,094.90 | 92.71 | -0.54% |
| Nikkei 225 | 36,442.43 | 209.92 | 0.58% |
| NZX 50 Index | 12,572.53 | 253.47 | 2.06% |
| S&P 500 | 5,428.86 | 5.57 | -0.10% |
| S&P/ASX 200 | 7,850.70 | 23.90 | 0.31% |
| SSE Composite Index | 2,850.65 | 17.29 | -0.60% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Predictive Discovery Ltd PDI | 0.20 | 0.00 | 0.00% |
| Orora Ltd ORA | 2.39 | 0.12 | 5.29% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.85% |
| Droneshield Ltd DRO | 1.17 | 0.02 | 1.74% |
| Telstra Group Ltd TLS | 3.87 | 0.00 | 0.00% |
| Appen Ltd APX | 0.95 | 0.19 | 24.34% |
| Evolution Mining Ltd EVN | 4.06 | 0.25 | 6.56% |
| Mirvac Group MGR | 1.96 | 0.00 | 0.00% |
| Pilbara Minerals Ltd PLS | 2.85 | 0.00 | 0.00% |
| Pantoro Ltd PNR | 0.11 | 0.00 | 0.00% |